Park Ave Peptides — Clinical Reference Library — For Professional Use Only

Reference Tool

Compare Compounds

Place up to three reference compounds side by side to compare their molecular profile, pharmacokinetics, and handling.

Attributecagrilintidesemaglutidetirzepatide
Field of MedicineEndocrinology · Metabolic ResearchEndocrinology · Metabolic ResearchEndocrinology · Metabolic Research
Categoryincretinincretinincretin
FormulaC187H291N45O59C225H348N48O68
Molecular Weight~3800 Da4113.6 Da4813.5 Da
SequenceLong-acting amylin analog31-amino-acid GLP-1 analog with C18 fatty diacid39-amino-acid peptide with C20 fatty diacid moiety
CAS Number910463-68-22023788-19-2
Half-Life~7–8 days~7 days~5 days (preclinical / published clinical literature)
Route (research)Subcutaneous in research modelsSubcutaneous in research modelsSubcutaneous in research models
Onset / Steady-stateSteady-state after ~4–5 weeks of weekly dosingSteady-state typically reached after ~4 weeks of weekly dosing
Lyophilized Storage−20°C long term; 2–8°C short term (weeks). Protect from light.−20°C long term; 2–8°C short term (weeks). Protect from light.−20°C long term; 2–8°C short term (weeks). Protect from light.
Reconstituted Storage2–8°C, generally up to 14–28 days depending on compound.2–8°C, generally up to 14–28 days depending on compound.2–8°C, generally up to 14–28 days depending on compound.